What is the best dose of aspirin in association with P2Y12 antagonists?

被引：3
|
作者：
Cattaneo, Marco [1 ]
机构：
[1] Univ Milan, Osped San Paolo, I-20142 Milan, Italy
来源：
HEART | 2011年 / 97卷 / 03期
关键词：
P2Y(12); RECEPTOR;
D O I：
10.1136/hrt.2010.216812
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：263 / 264
页数：2
相关论文
共 50 条
  • [31] P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
    Gragnano, Felice
    Cao, Davide
    Pirondini, Leah
    Franzone, Anna
    Kim, Hyo-Soo
    von Scheidt, Moritz
    Pettersen, Alf-Age R.
    Zhao, Qiang
    Woodward, Mark
    Chiarito, Mauro
    McFadden, Eugene P.
    Park, Kyung Woo
    Kastrati, Adnan
    Seljeflot, Ingebjorg
    Zhu, Yunpeng
    Windecker, Stephan
    Kang, Jeehoon
    Schunkert, Heribert
    Arnesen, Harald
    Bhatt, Deepak L.
    Steg, Philippe Gabriel
    Calabro, Paolo
    Pocock, Stuart
    Mehran, Roxana
    Valgimigli, Marco
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (02) : 89 - 105
  • [32] Aspirin versus P2Y12 inhibitors with anticoagulation therapy for atrial fibrillation
    Fukaya, Hidehira
    Ako, Junya
    Yasuda, Satoshi
    Kaikita, Koichi
    Akao, Masaharu
    Matoba, Tetsuya
    Nakamra, Masato
    Miyauchi, Katsumi
    Hagiwara, Nobuhisa
    Kimura, Kazuo
    Hirayama, Atsushi
    Matsui, Kunihiko
    Ogawa, Hisao
    HEART, 2021, 107 (21) : 1731 - 1738
  • [33] Efficacy and Safety of Aspirin Combined with Low-Dose P2Y12 Receptor Antagonists in East Asian Patients Undergoing PCI A Meta-Analysis
    Hu, Xiankang
    Zhao, Weibo
    Zhang, Qiongyue
    Hu, Houyuan
    Luo, Suxin
    INTERNATIONAL HEART JOURNAL, 2021, 62 (04) : 742 - 751
  • [34] Short DAPT after DES: P2Y12 monotherapy is in, aspirin is out!
    Grines, Cindy L.
    Marshall, J. Jeffrey
    EUROPEAN HEART JOURNAL, 2019, 40 (31) : 2605 - 2606
  • [35] Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists
    Giossi, A.
    Pezzini, A.
    Del Zotto, E.
    Volonghi, I.
    Costa, P.
    Ferrari, D.
    Padovani, A.
    CURRENT DRUG TARGETS, 2010, 11 (03) : 380 - 391
  • [36] Effective and Safe Transition Between Intravenous and Oral P2Y12 Antagonists
    Schneider, David J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (20) : 2540 - 2541
  • [37] Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease
    Oliphant, Carrie S.
    Doby, J. Bradford
    Blade, Crystal L.
    Das, Kanak
    Mukherjee, Debabrata
    Das, Pranab
    CURRENT VASCULAR PHARMACOLOGY, 2010, 8 (01) : 93 - 101
  • [38] Genotypic and phenotypic assessment of platelet function and response to P2Y12 antagonists
    De Labriolle A.
    Doazan J.P.
    Lemesle G.
    Bonello L.
    Current Cardiology Reports, 2011, 13 (5) : 439 - 450
  • [39] Platelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists
    Tang, Jie
    Li, Mu-Peng
    Zhou, Hong-Hao
    Chen, Xiao-Ping
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (05) : 566 - 577
  • [40] P2Y12 receptor antagonists:: a rapidly expanding group of antiplatelet agents
    Cattaneo, M
    EUROPEAN HEART JOURNAL, 2006, 27 (09) : 1010 - 1012
12345